Dawn A. Kirschmann

4.2k total citations
39 papers, 3.4k citations indexed

About

Dawn A. Kirschmann is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dawn A. Kirschmann has authored 39 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Dawn A. Kirschmann's work include Angiogenesis and VEGF in Cancer (8 papers), Microbial metabolism and enzyme function (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dawn A. Kirschmann is often cited by papers focused on Angiogenesis and VEGF in Cancer (8 papers), Microbial metabolism and enzyme function (6 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Dawn A. Kirschmann collaborates with scholars based in United States, Canada and Sweden. Dawn A. Kirschmann's co-authors include Mary J.C. Hendrix, Elisabeth A. Seftor, Richard E.B. Seftor, Angela R. Hess, Katharine M. Hardy, Naira V. Margaryan, Paul S. Meltzer, Gina C. Schatteman, Lori L. Wallrath and Lynne‐Marie Postovit and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Dawn A. Kirschmann

39 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn A. Kirschmann United States 29 2.6k 1.2k 1.0k 475 409 39 3.4k
Hira Lal Goel United States 29 2.4k 0.9× 1.1k 1.0× 855 0.8× 632 1.3× 366 0.9× 54 3.6k
Naira V. Margaryan United States 28 2.1k 0.8× 1.1k 1.0× 720 0.7× 492 1.0× 278 0.7× 57 2.8k
Marya F. McCarty United States 29 2.0k 0.8× 1.1k 1.0× 869 0.9× 272 0.6× 436 1.1× 37 3.0k
Lynn M.G. Gardner United States 7 2.0k 0.8× 906 0.8× 1.1k 1.1× 286 0.6× 269 0.7× 8 2.6k
Dmitri Wiederschain United States 28 2.5k 1.0× 1.6k 1.3× 1.2k 1.2× 257 0.5× 321 0.8× 45 3.8k
Laurie E. Littlepage United States 26 2.7k 1.0× 1.5k 1.3× 1.2k 1.1× 860 1.8× 412 1.0× 41 4.1k
David Dankort Canada 25 2.6k 1.0× 2.0k 1.7× 581 0.6× 449 0.9× 567 1.4× 39 3.9k
Bruce I. Terman United States 22 2.6k 1.0× 684 0.6× 722 0.7× 473 1.0× 312 0.8× 35 3.2k
Olivier Peyruchaud France 29 1.9k 0.8× 1.7k 1.4× 493 0.5× 530 1.1× 311 0.8× 76 3.8k
Pamela Blaikie United States 14 2.2k 0.8× 918 0.8× 771 0.8× 476 1.0× 334 0.8× 15 3.0k

Countries citing papers authored by Dawn A. Kirschmann

Since Specialization
Citations

This map shows the geographic impact of Dawn A. Kirschmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn A. Kirschmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn A. Kirschmann more than expected).

Fields of papers citing papers by Dawn A. Kirschmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn A. Kirschmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn A. Kirschmann. The network helps show where Dawn A. Kirschmann may publish in the future.

Co-authorship network of co-authors of Dawn A. Kirschmann

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn A. Kirschmann. A scholar is included among the top collaborators of Dawn A. Kirschmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn A. Kirschmann. Dawn A. Kirschmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanolkar, Aaruni, Guorong Liu, Bridget Simpson, et al.. (2020). A case of aberrant CD8 T cell–restricted IL-7 signaling with a Janus kinase 3 defect–associated atypical severe combined immunodeficiency. Immunologic Research. 68(1). 13–27. 2 indexed citations
2.
Cajaiba, Mariana M., Lisa Dyer, James I. Geller, et al.. (2018). The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 124(16). 3381–3389. 52 indexed citations
3.
Khalkhali‐Ellis, Zhila, Dawn A. Kirschmann, Elisabeth A. Seftor, et al.. (2014). Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells. International Journal of Cancer. 136(5). E242–51. 14 indexed citations
4.
Seftor, Richard E.B., Angela R. Hess, Elisabeth A. Seftor, et al.. (2012). Tumor Cell Vasculogenic Mimicry. American Journal Of Pathology. 181(4). 1115–1125. 228 indexed citations
6.
Hardy, Katharine M., Dawn A. Kirschmann, Elisabeth A. Seftor, et al.. (2010). Regulation of the Embryonic Morphogen Nodal by Notch4 Facilitates Manifestation of the Aggressive Melanoma Phenotype. Cancer Research. 70(24). 10340–10350. 100 indexed citations
7.
Moss, Timothy J. M., Naira V. Margaryan, Elisabeth A. Seftor, et al.. (2006). A Requirement for Dimerization of HP1Hsα in Suppression of Breast Cancer Invasion. Journal of Biological Chemistry. 281(27). 18668–18676. 52 indexed citations
8.
Hendrix, Mary J.C., et al.. (2006). Lysyl oxidase regulates actin filament formation through the p130Cas/Crk/DOCK180 signaling complex. Journal of Cellular Biochemistry. 98(4). 827–837. 48 indexed citations
9.
Kirschmann, Dawn A., et al.. (2005). Tumor suppressor gene Maspin and hypoxia inversely regulate lysyl oxidase-facilitated breast cancer motility.. Cancer Research. 65. 57–58. 1 indexed citations
10.
Schaft, Daisy W.J. van der, Femke Hillen, Patrick Pauwels, et al.. (2005). Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia. Cancer Research. 65(24). 11520–11528. 168 indexed citations
11.
Hendrix, Mary J.C., Elisabeth A. Seftor, Dawn A. Kirschmann, Vito Quaranta, & Richard E.B. Seftor. (2003). Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells. Annals of the New York Academy of Sciences. 995(1). 151–161. 91 indexed citations
12.
Seftor, Elisabeth A., Paul S. Meltzer, Dawn A. Kirschmann, et al.. (2002). Molecular determinants of human uveal melanoma invasion and metastasis. Clinical & Experimental Metastasis. 19(3). 233–246. 131 indexed citations
13.
Seftor, Elisabeth A., Paul S. Meltzer, Gina C. Schatteman, et al.. (2002). Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Critical Reviews in Oncology/Hematology. 44(1). 17–27. 118 indexed citations
14.
Hendrix, Mary J.C., Elisabeth A. Seftor, Dawn A. Kirschmann, & Richard E.B. Seftor. (2000). Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Research. 2(6). 417–22. 81 indexed citations
15.
Kirschmann, Dawn A., et al.. (1999). Differentially expressed genes associated with the metastatic phenotype in breast cancer. Breast Cancer Research and Treatment. 55(2). 125–134. 96 indexed citations
16.
Khalkhali‐Ellis, Zhila, Gary A. Bulla, Larry S. Schlesinger, et al.. (1999). C1q-Containing Immune Complexes Purified from Sera of Juvenile Rheumatoid Arthritis Patients Mediate IL-8 Production by Human Synoviocytes: Role of C1q Receptors. The Journal of Immunology. 163(8). 4612–4620. 19 indexed citations
17.
Woulfe, Susan L., Christine P. Bono, Dawn A. Kirschmann, et al.. (1995). Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis & Rheumatism. 38(12). 1744–1753. 26 indexed citations
18.
Kirschmann, Dawn A. & Donna M. Murasko. (1992). Splenic and inguinal lymph node T cells of aged mice respond differently to polyclonal and antigen-specific stimuli. Cellular Immunology. 139(2). 426–437. 59 indexed citations
19.
Kirschmann, Dawn A. & Donna M. Murasko. (1992). Effect of exogenous cytokines on the inhibition of macrophage-induced, antigen-specific T cell proliferation by poly(I:C). Clinical Immunology and Immunopathology. 65(3). 300–307. 3 indexed citations
20.
Kirschmann, Dawn A. & Donna M. Murasko. (1991). Inhibition of macrophage-induced antigen-specific T lymphocyte proliferation by poly I:C: Strain and antigen independence. Cellular Immunology. 135(1). 16–26. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026